Skip to main content

Table 1 Correlations between ACTN1 expression and clinicopathologic parameters in HCC patients

From: ACTN1 supports tumor growth by inhibiting Hippo signaling in hepatocellular carcinoma

Variable

ACTN1 (n)

Low (nā€‰=ā€‰41)

High (nā€‰=ā€‰116)

P-value

Age

ā€ƒā‰¤ 50ā€‰years

20

53

0.733

ā€ƒ>ā€‰ 50ā€‰years

21

63

Gender

ā€ƒFemale

7

21

0.882

ā€ƒMale

34

95

Hepatitis history

ā€ƒYes

32

91

0.957

ā€ƒNo

9

25

Gamma-glutamytransferase

ā€ƒā‰¤ 50(U/L)

13

40

0.747

ā€ƒ>ā€‰ 50(U/L)

28

76

*Alpha-fetoprotein

ā€ƒā‰¤ 20ā€‰ng/mL

19

27

0.005

ā€ƒ>ā€‰ 20ā€‰ng/mL

22

89

*Tumor thrombus

ā€ƒYes

7

41

0.029

ā€ƒNo

34

75

Tumor differentiation

ā€ƒI-II

15

44

0.878

ā€ƒIII

26

72

Vascular invasion

ā€ƒYes

18

36

0.136

ā€ƒNo

23

80

*Tumor size

ā€ƒā‰¤ 5ā€‰cm

35

79

0.033

ā€ƒ>ā€‰ 5ā€‰cm

6

37

*TNM stage

ā€ƒI-II

33

73

0.039

ā€ƒIII

8

43

  1. Pearsonā€™s Ļ‡2 test was used. The asterisk indicates P-values with significant differences